High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow

This publication has 24 references indexed in Scilit:

• Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer
  Transplantation and Cellular Therapy, 2000
• Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer
  New England Journal of Medicine, 2000
• Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells
  Bone Marrow Transplantation, 1999
• Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma
  Bone Marrow Transplantation, 1998
• Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver
  Bone Marrow Transplantation, 1998
• High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
  Journal of Clinical Oncology, 1997
• Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses
  Bone Marrow Transplantation, 1997
• A Comparison of Immunohistochemistry, Two-Color Immunofluorescence, and Flow Cytometry with Cell Sorting for the Detection of Micrometastatic Breast Cancer in the Bone Marrow
  Journal of Hematotherapy, 1996
• Peripheral Blood Stem Cell Transplantation
  Published by Springer Nature ,1995
• High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
  Journal of Clinical Oncology, 1988